Edgewise Therapeutics Inc.

---

Edgewise ups R&D spending as pharma firm focuses on cardiovascular pipeline

 August 6, 2026 4:00:12 pm

---

Edgewise closes muscular-dystrophy biz sale in deal that could top $2.6M

 July 13, 2026 12:33:32 pm

---

BizWest unveils inaugural ‘Startups to Watch’

 July 8, 2026 2:59:15 pm

---

Edgewise boosts R&D spending as drug trials bear promising results

 May 8, 2026 7:14:38 am

---

Edgewise boosts R&D spending in Q4 with drug milestones in sight

 February 27, 2026 6:56:10 am

---

Edgewise Therapeutics’ loss grows as R&D expenses increase

 November 10, 2025 3:22:12 pm

---

Edgewise maintains strong cash balance in Q2

 August 7, 2025 7:22:21 am

---

Edgewise boosted 1Q balance sheet with stock sale

 May 8, 2025 11:18:54 am

---

Edgewise Therapeutics selling $200M in stock to support drug commercialization

 April 2, 2025 3:26:37 pm

---

Edgewise Therapeutics boosted R&D spending in final quarter of 2024

 March 3, 2025 2:47:22 pm

Next Page »